Axonics Modulation Technologies Inc Asset Resilience Ratio
Axonics Modulation Technologies Inc asset resilience ratio. Axonics Modulation Technologies Inc (AXNX) has an Asset Resilience Ratio of 13.66% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Axonics Modulation Technologies Inc balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Axonics Modulation Technologies Inc (2016–2023)
Asset resilience ratio of Axonics Modulation Technologies Inc from 2016 to 2023. This chart shows how Axonics Modulation Technologies Inc's Asset Resilience Ratio has changed over time. See AXNX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Axonics Modulation Technologies Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Axonics Modulation Technologies Inc asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $105.77 Million | 13.66% |
| Total Liquid Assets | $105.77 Million | 13.66% |
Asset Resilience Insights
- Moderate Liquidity: Axonics Modulation Technologies Inc has 13.66% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Axonics Modulation Technologies Inc Industry Peers by Asset Resilience Ratio
Compare Axonics Modulation Technologies Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Epitomee Medical Ltd
TA:EPIT |
Medical Devices | 0.24% |
|
Aroa Biosurgery Ltd
AU:ARX |
Medical Devices | 12.13% |
|
ViroGates A/S
CO:VIRO |
Medical Devices | 225.94% |
|
Spineguard
PA:ALSGD |
Medical Devices | 9.27% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
Axonics Modulation Technologies Inc Asset Resilience Ratio by Year (2016–2023)
Axonics Modulation Technologies Inc asset resilience ratio by year from 2016 to 2023. The table below shows the annual Asset Resilience Ratio data for Axonics Modulation Technologies Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 33.36% | $240.15 Million | $719.92 Million | +15.41pp |
| 2022-12-31 | 17.95% | $118.36 Million | $659.35 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $547.95 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $342.21 Million | -- |
| 2019-12-31 | 5.73% | $12.59 Million | $219.82 Million | -28.72pp |
| 2018-12-31 | 34.45% | $59.22 Million | $171.91 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $29.41 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $10.86 Million | -- |
About Axonics Modulation Technologies Inc
Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retent… Read more